Roche Egypt, the leading global company in pharmaceuticals and diagnostic tests, announced the hosting of the second edition of the Roche Forum for Personalized Care in the Middle East next Friday, December 1, in Egypt’s new administrative capital. This aligns with its longstanding commitment to enhancing the healthcare system in the Middle East, especially after the success of the first edition last year in Dubai, United Arab Emirates.
Personalized Healthcare Forum serves as a platform for presenting advanced solutions developed in collaboration with partners from across the region in the field of personalized healthcare. This year’s edition will focus on personalized healthcare and precision medicine in oncology, real-world data (RWD), digital pathology, and other key topics in the medical field.
The forum’s opening will be attended by Influential figures in the health sector, such as Dr. Hamdy Abdel Azim, Professor of Clinical Oncology at Cairo University and Dr. Hesham El-Ghazali, Head of Presidential Initiative of Women’s Health and Professor of Clinical Oncology at Ain Shams University, as well as Dr. Alexander Meszaros, Global Chief Diagnostic Strategy Executive from Switzerland, in addition to Dr. Mehlika Hazar Rethinam and Dr. Eliane Cortez, clinical genomics scientists, and foundation medicine experts from the United States and Australia.
The forum, spanning two days, will include participants from foreign countries such as Germany, Spain, and England, in addition to Arab countries like Lebanon, Saudi Arabia, Qatar, and others.
The opening session will feature Dr. Mohamed Swilam, the General Manager of Roche Pharmaceuticals, and Dr. Liliane Kanaan, the General Manager of Roche Diagnostics in Egypt, welcoming attendees and shedding light on Roche’s vision for personalized healthcare and its impact on patient outcomes and societal costs.
